Search by Drug Name or NDC

    NDC 00169-2101-25 NOVOLOG 100 [iU]/mL Details

    NOVOLOG 100 [iU]/mL

    NOVOLOG is a INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is INSULIN ASPART.

    Product Information

    NDC 00169-2101
    Product ID 0169-2101_99351c0b-1c32-4eaf-8bc0-68079866d80c
    Associated GPIs 2710400200D220
    GCN Sequence Number 044341
    GCN Sequence Number Description insulin aspart INSULN PEN 100/ML (3) SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 92336
    HICL Sequence Number 020769
    HICL Sequence Number Description INSULIN ASPART
    Brand/Generic Brand
    Proprietary Name NOVOLOG
    Proprietary Name Suffix n/a
    Non-Proprietary Name insulin aspart
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN ASPART
    Labeler Name Novo Nordisk
    Pharmaceutical Class Insulin Analog [EPC], Insulin [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA020986
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-2101-25 (00169210125)

    NDC Package Code 0169-2101-25
    Billing NDC 00169210125
    Package 5 SYRINGE, PLASTIC in 1 CARTON (0169-2101-25) / 3 mL in 1 SYRINGE, PLASTIC (0169-2101-12)
    Marketing Start Date 2021-05-25
    NDC Exclude Flag N
    Pricing Information N/A